Skip to main content

RHUMBLINE ADVISERS

Position in TRVI — Trevi Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in TRVI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,470,434
+$1,169,337 QoQ
Shares Held
132,463
+21.5% QoQ
Ownership
0.093%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 216 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in TRVI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. TRVI ranks #88 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TRVI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,470,434 132,463
2026-03-31 $1,301,097 109,061
2025-12-31 $1,326,143 105,922
2025-09-30 $1,052,451 115,022
2025-06-30 $582,018 106,402
2025-03-31 $569,131 90,482
2024-12-31 $329,080 79,874
2024-09-30 $273,783 81,971
2024-06-30 $224,149 75,218
2024-03-31 $179,244 51,955
2023-12-31 $68,961 51,464
2023-09-30 $118,312 54,272
2023-06-30 $119,636 50,057